The Beijing Genomics Institute purchased 11 additional Genome Anlyzers from Illumina, bringing their total number of Illumina analyzers to 17. The purchase, completed in March, was called a “multi-million dollar” transaction. With the new machines, which are based on massively parallel technology, BGI has the capacity to sequence more than two human genomes to 25x coverage per week. More details...

Stock Symbol: (NSDQ: ILMN)